Neuropsychiatry

Here: devastating short- and long-term behavioral and physiological effects of methamphetamine neurotoxicity and the implications for treatment.

Is the hippo [campus] an endangered species?

Unrelenting belief in the goodness of humankind while confronting an uncommon disease.

Details of a randomized trial of an alpha-7 nicotinic receptor agonist in schizophrenia.

Three new studies focus on risk factors for the development of depressive disorders.

A brief psychosocial tool that offers compassionate, tailored care using existential neuroscience, a new perspective for conducting bedside psychotherapy.

New insights into neural pathways that play a role in anorexia nervosa, bulimia nervosa, and binge eating disorder.

Eating disorders are second only to substance-abuse disorders in having the highest mental illness mortality rate. How do we assist the patient in moving forward?

With aging, a multitude of medical conditions can occur and/or existing conditions can be exacerbated, contributing causally to or amplifying neuropsychiatric comorbidities.

This nondrug intervention may enhance cognition in children with ADHD.

There is more to BPD than meets the eye. A complex interaction exists between environmental, anatomical, functional, genetic, and epigenetic factors.

A quick guide to common neurodevelopmental conditions and their associated late-life neuropsychiatric manifestations.

The identification of a genetic risk factor has shed light on the underlying neurobiology of the disorder.

Groundbreaking work by a Harvard team represents a bold step in our journey toward understanding schizophrenia.

ECT has been an acute intervention for patients with severe resistant MDD, but what is its effect on brain volume?

A Q&A on the emerging field of positive psychiatry.

Brain-based biomarkers identify more biologically homogeneous categories of psychosis than do clinical diagnoses.

Neuroinflammation may be a culprit in the development of psychosis. What are the clinical implications?

The author scrutinizes the results of a new pilot study that finds the Fisher Wallace Stimulator® effective in treating bipolar depression.

Researchers looked into the efficacy and value of TMS for treatment-resistant depression.

An update on what happens in the brain when the mind is engaged in psychotherapy.

The challenges of recognizing behaviors such as hypersexuality, gambling, and excessive buying in Parkinson disease are discussed, as are ways to address them while still managing the underlying condition.

Simply telling patients “we don’t know how ECT works” neglects our abundant knowledge of what this treatment does. The authors review biological actions of ECT and discuss future directions for research.

Can schizophrenia be distinguished from bipolar disorder via gray matter volume?

We are a long way from understanding the complex neural basis for behaviors such as mentalization. But, we can mentally imagine the scientific pursuit of questions, one after another, that might get us to that goal.

A new network-based neuroimaging study seeks to identify biomarkers across the spectrum of impairment in schizophrenia.

The prevalence of chronic hepatitis C virus infection is among the highest in patients with severe underlying mental illness. Here: clinical information on the interface of HCV infection and psychiatric disorders.

Many people like to spend at least part of their free time playing video games. However, for some, what starts as innocent recreation becomes an addiction and, at times, tragedy ensues.

This review focuses on post-stroke depression, apathy, anxiety, and PTSD, because these disorders occur and have been studied most frequently.

Your patient is recovering from a traumatic brain injury. He asks you, “Doc, why do I need so much extra sleep?”